제45차 대한암학회 학술대회 및 제5차 국제암컨퍼런스 1 : 2019-06-20
교육일자 : 2019-06-20
교육장소 : 서울드래곤시티 한라홀 외  
교육주제 : 제45차 대한암학회 학술대회 및 제5차 국제암컨퍼런스 1      
주최기관 : 대한암학회
담당자 : 이희연
연락처 : 070-8850-4459  
이메일 : cancer4@kams.or.kr      
교육종류 : 내과, 외과, 소아청소년과, 산부인과, 정형외과, 신경외과, 흉부외과, 성형외과, 안과, 이비인후과, 피부과, 비뇨의학과, 영상의학과, 방사선종양학과, 마취통증의학과, 신경과, 재활의학과, 결핵과, 진단검사의학과, 병리과, 가정의학과, 핵의학과, 응급의학과예방의학, 해부학, 생리학, 생화학, 분자생물학, 미생물학, 약리학
참석예상인원 : 1500명
희망평점 : 6점  
지역 : 서울특별시
교육시간 : 40 시간 20분  
세부수강료 150,000원      
비고 [사전등록] 1.회원: 1)교수 및 전문의: 10만원/ 2)전공의,연구원: 5만원/ 3)업체 및 연구소: 10만원 2.비회원: 1)교수 및 전문의: 12만원/ 2)전공의,연구원: 7만원/ 3)업체 및 연구소: 12만원 [현장등록] 1.회원: 1)교수 및 전문의: 12만원/ 2)전공의,연구원: 7만원/ 3)업체 및 연구소: 12만원 2.비회원: 1)교수 및 전문의: 15만원/ 2)전공의,연구원: 9만원/ 3)업체 및 연구소: 15만원      

구분 월일 강의실 시간 교육제목  강사명(소속) 필수과목
교육시간 06-20 HANRA A 09:00~09:25 Staging and pathologic features related to cancer biology  김규래(울산의대) 
교육시간 06-20 HANRA A 09:25~09:50 Oncologic imaging: Evolving images for evolving treatments  김경원(울산의대) 
교육시간 06-20 HANRA A 09:50~10:15 Armamentarium in medical oncology: Old and new  박인근(가천의대) 
교육시간 06-20 HANRA A 10:15~10:40 Clinical trials: How to add translational components  최윤지(고려의대) 
교육시간 06-20 HANRA B 09:00~09:25 Pressurized intraperitoneal aerosol chemotherapy  안상훈(서울의대) 
교육시간 06-20 HANRA B 09:25~09:50 Value of extra nodal tumor deposit and extramural vascular invasion in colorectal cancer  박선진(경희의대) 
교육시간 06-20 HANRA B 09:50~10:15 Alternative preoperative treatment in advanced rectal cancer  김혜진(경북의대) 
교육시간 06-20 HANRA B 10:15~10:40 Update of treatment for peritoneal metastasis in gastric cancer  김종한(고려의대) 
교육시간 06-20 HANRA C 09:00~09:30 Radiation therapy and anti-tumor immunity; immunological mechanisms of abscopal effect  박세광(인제의대) 
교육시간 06-20 HANRA C 09:30~10:00 A strategy of the combination of radiotherapy and immune checkpoint blockade  김진호(서울의대) 
교육시간 06-20 HANRA C 10:00~10:30 Propagation of abscopal effect from local therapy  박경화(고려의대) 
토론 06-20 HANRA C 10:30~10:40 Q&A Discussion  () 
교육시간 06-20 SHILLA A 09:00~09:25 Application of proteomics in translational cancer research  김재영(충남대) 
교육시간 06-20 SHILLA A 09:25~09:50 Extracellular vesicles in cancer: Cell-to-cell mediators of metastasis  김한상(연세의대) 
교육시간 06-20 SHILLA A 09:50~10:15 Application of robotic surgery for advanced gynecologic cancers  백지흠(아주의대) 
교육시간 06-20 SHILLA A 10:15~10:40 The defense mechanisms of polarized epithelial cells to suppress EMT and tumor metastasis  정해윤(성균관의대) 
휴식 06-20  10:40~11:00 Coffee Break  () 
교육시간 06-20 HANRA 11:00~11:30 How do tumor cells grow within lymph node?  고규영(카이스트) 
교육시간 06-20 HANRA 11:30~12:20 Progress through the new American NCI National Clinical Trials Network: NRG Oncology as a case study  Walter J. Curran(Winship Cancer Institute of Emory University USA) 
교육시간 06-20 HANRA A 12:20~13:20 Individualized treatment decision for optimal sequence in mCRC, with aflibercept  TBA(TBA) 
교육시간 06-20 HANRA B 12:20~13:20 Liposomal irinotecan, new hope for the treatment of metastatic pancreatic cancer  유창훈(울산의대) 
교육시간 06-20 HANRA C 12:20~13:20 Cutting-edge front-line treatment for advanced non-small cell lung cancer  김태민(서울의대) 
교육시간 06-20 SHILLA A 12:20~13:20 Therapeutic strategy for maximizing overall survival for ALK/ROS1+ NSCLC  Takashi Seto(Kyushu Cancer Center Japan) 
교육시간 06-20 HANRA A 13:20~13:45 Epigenetic alterations in gastric epithelial and stromal cells as diagnostic and therapeutic targets  Toshikazu Ushijima(National Cancer Center Research Institute Japan) 
교육시간 06-20 HANRA A 13:45~14:10 Integrated proteogenomic analysis of gastric cancers  황대희(서울대) 
교육시간 06-20 HANRA A 14:10~14:35 Stem cell origin of gastric cancers and their niche  Yoku Hayakawa(The University of Tokyo Japan) 
교육시간 06-20 HANRA A 14:35~15:00 Targeting interaction between fibrotic stroma and cancer cell in gastric cancer  허훈(아주의대) 
교육시간 06-20 HANRA B 13:20~13:45 The first biomarker-defined tumor indication: Pembrolizumab for MSI-H tumors  Kenneth Emancipator(MSD USA) 
교육시간 06-20 HANRA B 13:45~14:10 Development of larotrectinib in NTRK fusion positive tumors  TBA(TBA) 
교육시간 06-20 HANRA B 14:10~14:35 Challenges in trial design in tissue agnostic drug development  Susan Galloway Hilsenbeck(Dan L Duncan Comprehensive Cancer Center Baylor College of Medicine USA) 
교육시간 06-20 HANRA B 14:35~15:00 Challenges of tissue agnostic drug approval and utility  안명주(성균관의대) 
교육시간 06-20 HANRA C 13:20~13:45 Thyroid oncology I  Xiaolei Wang(The Cancer Institute and Hospital Chinese Academy of Medical Sciences China) 
교육시간 06-20 HANRA C 13:45~14:10 Heand and neck cancer I  Laiping Zhong(Shanghai Ninth People’s Hospital Shanghai jiaotong university School of Medicine China) 
교육시간 06-20 HANRA C 14:10~14:35 Thyroid oncology II  TBA(TBA) 
교육시간 06-20 HANRA C 14:35~15:00 Heand and neck cancer II  TBA(TBA) 
교육시간 06-20 SHILLA A 13:20~13:55 Unleashing the innate and adoptive immune systems for the treatment of pediatric solid tumors  Robbie G. Majzner(Stanford University School of Medicine USA) 
교육시간 06-20 SHILLA A 13:55~14:30 Immune checkpoint blockade immunotherapy for advanced solid tumor of childhood  Yasushi Fuchimoto(International University of Health and Welfare School of Medicine Japan) 
교육시간 06-20 SHILLA A 14:30~15:00 Exploring combination therapy with B cell and monocyte-based cancer vaccines  강창율(서울대 약대) 
교육시간 06-20 BAEKJE A 13:20~13:40 Establishing database platform of KGOG  최철훈(성균관의대) 
교육시간 06-20 BAEKJE A 13:40~14:00 Beyond the specialty: Integration of inter-departmental ability  문용화(차의대) 
교육시간 06-20 BAEKJE A 14:00~14:20 Tips and tricks of recruiting study population  박원(성균관의대) 
교육시간 06-20 BAEKJE A 14:20~14:40 Development of ‘good’ clinical trial protocol  강석범(국립암센터) 
토론 06-20 BAEKJE A 14:40~15:00 Panel Discussion  () 
교육시간 06-20 BAEKJE B 13:20~13:45 Mitochondrial UQCRB, a new player in tumor angiogenesis  권호정(연세대) 
교육시간 06-20 BAEKJE B 13:45~14:10 Endothelial Notch signaling promotes tumor progression and metastasis  Andreas Fischer(German Cancer Research Center (DKFZ) Germany) 
교육시간 06-20 BAEKJE B 14:10~14:35 Deciphering the origin of somatic mutations in brain tumors  이정호(카이스트) 
교육시간 06-20 BAEKJE B 14:35~15:00 Vascular abnormalities in mouse brain tumor models  김인준(카이스트) 
교육시간 06-20 GOGURYEO 13:20~13:50 Recent updates in combination of pembrolizumab and TKIs  TBA(TBA) 
교육시간 06-20 GOGURYEO 13:50~14:20 Pembrolizumab for MSI-H solid tumor  TBA(TBA) 
교육시간 06-20 GOGURYEO 14:20~14:50 Durable response after discontinuation of pembrolizumab and re-challenge for patients experiencing progression after response  TBA(TBA) 
토론 06-20 GOGURYEO 14:50~15:00 Q&A Discussion  () 
휴식 06-20  15:00~15:20 Coffee Break  () 
교육시간 06-20 HANRA A 15:20~15:45 Recent challenges for precision medicine in colorectal cancer  Hideo Baba(Graduate School of Medical Sciences Kumamoto University Japan) 
교육시간 06-20 HANRA A 15:45~16:10 Next-generation sequencing-based clinical sequencing: Toward precision medicine in colorectal cancer  Toshifumi Wakai(Niigata University Graduate School of Medical and Dental Sciences Japan) 
교육시간 06-20 HANRA A 16:10~16:35 Application of clinical NGS in colorectal cancer: Asan Medical Center experience  김지훈(울산의대) 
교육시간 06-20 HANRA A 16:35~17:00 Precision medicine in colorectal cancer: Case review  김진원(서울의대) 
교육시간 06-20 HANRA B 15:20~15:55 Pragmatic clinical research and barriers  Edward Kim(Atrium Health Levine Cancer Institute USA) 
교육시간 06-20 HANRA B 15:55~16:25 Untold reality in medical device development  오승준(서울의대) 
교육시간 06-20 HANRA B 16:25~17:00 Innovations in clinical trials and future  김지현(서울의대) 
교육시간 06-20 HANRA C 15:20~15:40 Current status and future of genetic test  임명철(국립암센터) 
교육시간 06-20 HANRA C 15:40~16:00 Mismatch repair gene and gynecologic cancer  최민철(차의대) 
교육시간 06-20 HANRA C 16:00~16:20 BRCAness and synthetic lethality  이성종(가톨릭의대) 
교육시간 06-20 HANRA C 16:20~16:40 Surveillance and risk-reducing strategies for breast cancer in women with BRCA mutations  박형석(연세의대) 
교육시간 06-20 HANRA C 16:40~17:00 Precision medicine in gynecologic cancer  주웅(이화의대) 
교육시간 06-20 SHILLA A 15:20~15:45 Studies on developing prediction models based on cancer transcroptome and clinical information  이민호(가톨릭대) 
교육시간 06-20 SHILLA A 15:45~16:10 Enhancer remodeling and microRNA alterations are associated with acquired resistance to ALK inhibitors  김미랑(한국생명공학연구원) 
교육시간 06-20 SHILLA A 16:10~16:35 Genomic research and clinical applications in breast cancer  한원식(서울의대) 
교육시간 06-20 SHILLA A 16:35~17:00 Molecular classification reveals new driver transcripts in liver cancer  우현구(아주의대) 
교육시간 06-20 BAEKJE A 15:20~15:50 The galapagos of the medical research field - An opportunity for the future of medicine in the Korean Peninsula  김신곤(고려의대) 
교육시간 06-20 BAEKJE A 15:50~16:20 R&D initiatives in DPRK  신희영(서울의대) 
교육시간 06-20 BAEKJE A 16:20~16:50 Experience of healthcare project between the South & North Korea  이윤상(나눔인터내셔널) 
토론 06-20 BAEKJE A 16:50~17:00 Q&A Discussion  () 
교육시간 06-20 BAEKJE B 15:20~17:00 Oral Presentations / International Sessions  () 
교육시간 06-20 GOGURYEO 15:20~15:55 How do we go through the HER+ GC?  김진수(서울의대) 
교육시간 06-20 GOGURYEO 15:55~16:30 From the start to future in antiangiogenic agent in GC  라선영(연세의대) 
교육시간 06-20 GOGURYEO 16:30~17:00 Real world evidence of ramucirumab in GC  이근욱(서울의대) 
교육시간 06-20 HANRA A 17:00~18:00 Oral Presentations / International Sessions  () 
교육시간 06-20 HANRA B 17:00~18:00 Oral Presentations / International Sessions  () 
교육시간 06-20 HANRA C 17:00~18:00 Oral Presentations / International Sessions  () 
교육시간 06-20 BAEKJE A 17:00~18:00 Oral Presentations / International Sessions  () 
교육시간 06-20 BAEKJE B 17:00~18:00 Oral Presentations / International Sessions  ()